N. L. Ramakers-Van Woerden

Statistics

Publications

Citations

299

H-Index

Active since

2000

Affiliations

Stichting Kinderoncologie Nederland(Current)

Erasmus MC - Sophia Children’s Hospital

Erasmus University Rotterdam

Justus-Liebig-Universität Gießen

Charité - Universitätsmedizin Berlin

N. L. Ramakers-Van Woerden is an author at Stichting Kinderoncologie Nederland specializing in acute lymphoblastic leukemia biology, cytogenetics, and cancer cytogenetics.

Publications per year

2000–2004

Publications

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

N. L. Ramakers-Van Woerden, R. Pieters, A. H. Loonen et al. · PubMed · 2000 · 151 citations

Life Sciences, Genetics, Molecular Genetics +12

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

N. L. Ramakers-Van Woerden, H. Berna Beverloo, Bruce M. Camitta et al. · Leukemia · 2004 · 90 citations · Full text

Medicine, Oncology, Pediatrics +13

In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T‐cell acute lymphoblastic leukaemia

N. L. Ramakers-Van Woerden, R. Pieters, R Släter et al. · British Journal of Haematology · 2001 · 32 citations

Life Sciences, Molecular Genetics, Oncology +15

In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups

N. L. Ramakers-Van Woerden, R. Pieters, D. Hoelzer et al. · Medical and Pediatric Oncology · 2002 · 26 citations

Medicine, Genetics, Oncology +17

1–4 of 4